Literature DB >> 7756095

Effects of gemfibrozil on the oxygen transport properties of erythrocytes.

R Scatena1, G Nocca, I Messana, P De Sole, S Baroni, C Zuppi, M Castagnola, B Giardina.   

Abstract

1. In the present study we have investigated the effects of the relatively low plasma concentrations of gemfibrozil (GFZ) found in clinical practice on the oxygen dissociation curve (ODC) of erythrocytes. 2. ODCs were measured at 30 degrees C and 37 degrees C and at pH 7.4: a) both on HbA solution and erythrocytes incubated in vitro with gemfibrozil and clofibric acid; b) on erythrocytes from healthy volunteers treated with a single oral dose of gemfibrozil. 3. These experiments showed a significant drug-induced shift of the ODC towards lower O2 affinity values without any significant modification of metabolic parameters of erythrocytes such as intracellular pH and intraerythrocytic levels of ATP and DPG. 4. In our experimental conditions gemfibrozil appears to lower both in vitro and in vivo, the partial pressure of oxygen required to give 50% of the haemes saturated with oxygen (P50) of erythrocytes from the control value of 24 +/- 0.5 mm Hg to 29 +/- 0.5 mm Hg (mean +/- s.d.; P < 0.02 by ANOVA). 5. These data clearly indicate that therapeutic doses of gemfibrozil may influence the oxygen transport properties of red cells. This effect could have relevant pharmacological and toxicological implications.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756095      PMCID: PMC1364977          DOI: 10.1111/j.1365-2125.1995.tb04405.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

Review 1.  Could manipulation of the binding affinity of haemoglobin for oxygen be used clinically to sensitize tumours to radiation?

Authors:  D G Hirst; P J Wood
Journal:  Radiother Oncol       Date:  1991       Impact factor: 6.280

2.  T-state hemoglobin with four ligands bound.

Authors:  M C Marden; J Kister; B Bohn; C Poyart
Journal:  Biochemistry       Date:  1988-03-08       Impact factor: 3.162

3.  Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy.

Authors:  D W Siemann; K L Alliet; L M Macler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-05       Impact factor: 7.038

4.  Determination of intracellular pH by 31P magnetic resonance.

Authors:  R B Moon; J H Richards
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

5.  Bezafibrate lowers oxygen affinity of haemoglobin.

Authors:  M F Perutz; C Poyart
Journal:  Lancet       Date:  1983-10-15       Impact factor: 79.321

6.  Measurement of binding of gaseous and nongaseous ligands to hemoglobins by conventional spectrophotometric procedures.

Authors:  B Giardina; G Amiconi
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Physiological and x-ray studies of potential antisickling agents.

Authors:  D J Abraham; M F Perutz; S E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

9.  Modification of the haemoglobin oxygen dissociation curve in whole blood by a compound with dual action.

Authors:  R M Hyde; D J Livingstone; R A Patterson; J F Batchelor; W R King
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

10.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors:  V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

  10 in total
  3 in total

1.  Oxidative effects of gemfibrozil on anion influx and metabolism in normal and Beta-thalassemic erythrocytes: physiological implications.

Authors:  Ester Tellone; Silvana Ficarra; Bruno Giardina; Roberto Scatena; Annamaria Russo; M Elisabetta Clementi; Francesco Misiti; Ersilia Bellocco; Antonio Galtieri
Journal:  J Membr Biol       Date:  2008-09-29       Impact factor: 1.843

Review 2.  Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

Authors:  C M Spencer; L B Barradell
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

3.  Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

Authors:  Roberto Scatena; Patrizia Bottoni; Bruno Giardina
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.